Danimer Scientific Inc
General ticker "DNMR" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $551.7M
Danimer Scientific Inc does not follow the US Stock Market performance with the rate: -26.5%.
Estimated limits based on current volatility of 16.0%: low 2.58$, high 3.57$
Factors to consider:
- US accounted for 86.1% of revenue in the fiscal year ended 2022-12-31
- Current price 70.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [13.10$, 59.87$]
- 2024-12-30 to 2025-12-30 estimated range: [5.88$, 25.95$]
Financial Metrics affecting the DNMR estimates:
- Negative: Non-GAAP EPS, $ of -60.80 <= 0.10
- Negative: Operating profit margin, % of -72.91 <= 1.03
- Negative: Operating cash flow per share per price, % of -1.10 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of 6.46 <= 6.94
- Negative: negative Net income
- Negative: Industry operating profit margin (median), % of 6.58 <= 6.82
- Negative: Industry inventory ratio change (median), % of 0.71 > 0.49
Short-term DNMR quotes
Long-term DNMR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $58.75MM | $53.22MM | $46.68MM |
| Operating Expenses | $158.22MM | $240.65MM | $172.30MM |
| Operating Income | $-99.47MM | $-187.43MM | $-125.62MM |
| Non-Operating Income | $26.13MM | $6.87MM | $-29.54MM |
| Interest Expense | $0.76MM | $112.25MM | $0.00MM |
| R&D Expense | $20.27MM | $31.94MM | $29.24MM |
| Income(Loss) | $-73.34MM | $-180.57MM | $-155.15MM |
| Taxes | $-13.23MM | $-0.81MM | $0.32MM |
| Profit(Loss) | $-60.11MM | $-179.76MM | $-155.47MM |
| Stockholders Equity | $500.26MM | $377.61MM | $278.02MM |
| Inventory | $24.57MM | $32.74MM | $25.27MM |
| Assets | $838.60MM | $712.27MM | $698.13MM |
| Operating Cash Flow | $-62.96MM | $-61.84MM | $-47.26MM |
| Capital expenditure | $185.41MM | $164.49MM | $27.68MM |
| Investing Cash Flow | $-336.17MM | $-182.48MM | $-27.66MM |
| Financing Cash Flow | $306.20MM | $21.75MM | $84.03MM |
| Earnings Per Share* | $-0.65 | $-1.78 | $-1.52 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.